Radiology, Radiation Oncology · Tampa, FL
NPI
1679863658
Since 2011
Specialty
Radiology, Radiation Oncology
Code 2085R0001X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
601 S Armenia Ave
Tampa, FL, 33609
Phone (813) 353-8803
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.2M
14,260 services
Medicare patients, 2024
574
Average age 75
Drug cost, 2024
$15.1M
2,399 prescriptions
Company payments, 2025
$34K
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alexander Engelman was code 77014 (conventional radiation treatment), 1,667 times for 86 patients. In total Alexander Engelman billed 14,260 services in 54 codes, and Medicare paid $2.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 77014 Conventional Radiation Treatment | Office | 1,667 | 86 | $89.05 | $148K |
| G6015 Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 1,666 | 80 | $258.07 | $430K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 799 | 462 | $12.34 | $9,863 |
| 99214 Office E&M - Established | Office | 612 | 357 | $93.09 | $57K |
| 77300 Radiation Treatment Planning | Office | 472 | 136 | $49.10 | $23K |
| 77336 Radiation Treatment Planning | Office | 350 | 114 | $65.44 | $23K |
| 77427 Conventional Radiation Treatment | Office | 304 | 73 | $146.30 | $44K |
| 77373 Radiation Treatment Planning | Office | 245 | 50 | $722.53 | $177K |
| 99213 Office E&M - Established | Office | 159 | 150 | $58.08 | $9,234 |
| 99205 Office E&M - New | Office | 158 | 158 | $164.74 | $26K |
| 77334 Radiation Treatment Planning | Office | 153 | 121 | $93.47 | $14K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 147 | 22 | $137.79 | $20K |
| 77338 Radiation Treatment Planning | Office | 135 | 120 | $346.80 | $47K |
| 77301 Intensity Modulated Radiation Therapy | Office | 134 | 120 | $1,339.13 | $179K |
| 77263 Radiation Treatment Planning | Office | 131 | 125 | $122.25 | $16K |
By year: 2022 $2.5M for 11,219 services; 2023 $2.3M for 9,768 services; 2024 $2.2M for 14,260 services.
Medicare prescription drug claims, 2024
In 2024, the drug Alexander Engelman prescribed most often to Medicare patients was Erleada (Apalutamide), with 660 prescriptions and refills. In total Alexander Engelman wrote 2,399 Medicare prescriptions that cost $15.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Erleada Apalutamide | 660 | 674 | 128 | $9.6M |
| Orgovyx Relugolix | 420 | 425 | 80 | $1.1M |
| Tamsulosin Hcl Generic | 317 | 790 | 159 | $3,888 |
| Nubeqa Darolutamide | 234 | 234 | 43 | $3.1M |
| Ciprofloxacin Hcl Generic | 112 | 112 | 93 | $680 |
| Xtandi Enzalutamide | 65 | 69 | 14 | $933K |
| Methylprednisolone Generic | 61 | 64 | 43 | $443 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 33 | 51 | 15 | $225 |
| Lupron Depot Leuprolide Acetate | 29 | 100 | 14 | $198K |
| Eligard Leuprolide Acetate | 28 | 87 | 15 | $36K |
| Prednisone Generic | 27 | 35 | 12 | $95.08 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 23 | 65 | 12 | $404 |
| Abiraterone Acetate Generic | 22 | 22 | Under 11 | $34K |
| Oxycodone Hcl Generic | 20 | 20 | 16 | $519 |
| Tadalafil Generic | 19 | 31 | Under 11 | $1,156 |
Brand drugs: 1,480 claims; generic drugs: 919 claims; opioid claims: 70.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alexander Engelman $34K ($34K in general payments such as food, travel and fees) from 24 companies. The largest payer was Janssen Biotech, Inc. with $13K.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 43 | $13K |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 21 | $13K |
| Novartis Pharmaceuticals Corporation NVS | 7 | $3,388 |
| Astellas Pharma Global Development 4503.T | 1 | $1,650 |
| Janssen Global Services, LLC JNJ | 1 | $1,470 |
| Dendreon Pharmaceuticals LLC | 13 | $266 |
| Blue Earth Diagnostics | 9 | $201 |
| Pfizer Inc. PFE | 11 | $162 |
| Astellas Pharma US Inc 4503.T | 4 | $118 |
| Sumitomo Pharma America, Inc. 4506.T | 4 | $102 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.